Chunyong Xia

5PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2026
Ferric ion-mediated biomimetic mineralization of human serum albumin with doxorubicin and celastrol for enhanced antitumor therapy.

|Mar 21, 2026
A comprehensive study on drug-related dysphonia: a 20-year disproportionality analysis of the FAERS database.

Chunyong Xia, Ya Gan, Jie Liu

|Feb 17, 2026
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal nanoparticle-formulated and conventional anticancer irinotecan.

Chunyong Xia, Jie Liu, Zhongyang Ren

|Feb 05, 2026
Adverse Event Profile Differences Between Eliglustat and Miglustat: A Pharmacovigilance Study using the U.S. Food and Drug Administration Adverse Event Reporting System.

Ya Gan, Jie Liu, Chunyong Xia

|Aug 18, 2025
Adverse Event Profile Differences Between Metyrapone and Osilodrostat: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.

Chunyong Xia, Lanxin Hu, Ying Fan

Pageof 1

Frequent Collaborators